Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-995-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The reported data show that the test item C16-18,18'DETA-Amide_ethoxylated did not induce gene mutations in the S. typhimurium tester strains with and without mammalian metabolic activation. In conclusion the results of this bacterial reverse mutation assay were considered negative.
The reported data show that the test item C16-18,18'DETA-Amide_ethoxylated did not induce gene mutations in a chromosome aberration test on peripheral human lymphocytes with and without mammalian metabolic activation. In conclusion the results of this chromosome aberration assay were considered negative.
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-Guideline study.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: GB/T21794-2008 Chemicals-Test method of in vitro mammalian chromosome aberration
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- purity 86.8%
- Target gene:
- not applicable
- Species / strain / cell type:
- other: peripheral human lymphocytes (isolated from the blood of a healthy adult, non-smoking, male volunteers (26-31 years old))
- Details on mammalian cell type (if applicable):
- - Type and identity of media: culture medium consisted of RPMI 1640 medium supplemented with 20% (v/v) heat-inactivated foetal bovine serum, heparine, Colchicine, NADP and G-6-P, Mitomycin and Cyclophosphamide
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and ß-naphthoflavone
- Test concentrations with justification for top dose:
- Without and with S9-mix: 62.5, 31.2 and 15.6 µg/mL culture medium (4 h exposure time, 24 h fixation time)
- Vehicle / solvent:
- - Culture medium: RPMI 1640 (85%); FBS (15%), PHA (200 µg/L), heparin (10U/mL), penicillin (100U/mL), strptomycin (100 U/mL).
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Remarks:
- mitomycin C (-S9): 0.25 µg/mL (4 h exposure period), 0.2 and 0.3 µg/mL (24 h exposure period) and 0.1 and 0.15 µg/mL (48 h exposure period ), cyclophosphamide (+S9): 9.4 µg/mL for the 4 h exposure period (24 and 48 h fixation time)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4h; 24h
- Fixation time (start of exposure up to fixation or harvest of cells): 24h
SPINDLE INHIBITOR (cytogenetic assays): colchicine (1 µg/mL medium, 4h)
STAIN (for cytogenetic assays): Giemsa (5% (v/v))
NUMBER OF REPLICATIONS: duplicate in two independent experiments
NUMBER OF CELLS EVALUATED: 200 per concentration and solvent control group, 100 for positive control group.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- The chromosome aberration test was considered acceptable if it meets the following criteria:
a) The number of chromosome aberrations found in the solvent control cultures should reasonably be within the range of the laboratory historical control data.
b) The positive control substances should produce a statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations.
c) A homogeneous response between the replicate cultures was observed.
d) A possible precipitate present on the slides should not interfere with the scoring of chromosome aberrations.
A test substance was considered positive (clastogenic) in the chromosome aberration test if:
a) It induced a dose-related statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations.
b) A statistically significant and biologically relevant increase in the frequencies of the number of cells with chromosome aberrations was observed in the absence of a clear dose-response relationship.
A test substance was considered negative (not clastogenic) in the chromosome aberration test if none of the tested concentrations induced a statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations. - Species / strain:
- other: peripheral human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- in the continuous experiment at the highest dose of 300 µg/mL
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
In order to select the appropriate dose levels for the chromosome aberration test cytotoxicity data were obtained in a dose range finding test.
The cytotoxicity result showed that no cell survived and no mitotic phase occured at the concentrations tested over 62.5 µg/mL, and the mitotic index showed a significant reduction at the concentration of 62.5 µg/mL (>50%); There were no cytotoxicity at the concentration of 15.6 µg/mL.
According to the above results of cytotoxicity test, three doses of 62.5, 31.2, 15.6 µg/ml were used. - Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- negative
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13-06-2013 to 08-07-2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- Lot number: STO26977671
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- S. typhimurium TA 97
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix (rat; Arochlor 1254 induced)
- Test concentrations with justification for top dose:
- 10.0, 31.6, 100, 316, 1000 and 3160 µg / plate
- Vehicle / solvent:
- distilled water
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- without metabolic activation: TA 1535; TA 100; 1.5 µg/vessel
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 1,8-dihydroxy anthraquinone
- Remarks:
- without metabolic activation: TA 1537 and TA 102; 50 µg/vessel
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminofluorene
- Remarks:
- with metabolic activation: TA 97, TA 98, TA 100; 10 µg/vessel
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: Dexon
- Remarks:
- without metabolic activation: TA 97, TA 98, TA 102, 50 µg/vessel
- Details on test system and experimental conditions:
- The test was performed both in existence and absence of the S9mix by adopting plate incorporation method,
- Evaluation criteria:
- A test substance producing no biologically relevant positive response in any one of the bacterial strains tested is considered to be non-mutagenic in this system.
A biologically relevant response is described as follows:
If the number of revertants is at least twice the spontaneous reversion rate and shows a dose-response relationship, the result is positive. - Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: the substance was solved in distilled water.
- Precipitation: no precipitation was noted at all.
COMPARISON WITH HISTORICAL CONTROL DATA: The results of the negative and positive control cultures were within the range of the historical data generated by the testing lab.
- Conclusions:
- Interpretation of results:
negative
The reported data show that the test item C16-18,18'DETA-Amide_ethoxylated did not induce gene mutations in the S. typhimurium tester strains with and without mammalian metabolic activation. In conclusion the results of this bacterial reverse mutation assay were considered negative. - Executive summary:
The potential of C16-18,18'DETA-Amide_ethoxylated to induce gene mutations was examined in 5 Salmonella typhimurium strains TA 97, TA98, TA100, TA102 and TA1535 in two independent experiments, each carried out without and with metabolic activation (a microsomal preparation derived from Aroclor 1254-induced rat liver). The experiments were carried out as a plate incorporation test.
Six concentrations ranging from 62.5 to 1000 μg C16-18,18'DETA-Amide_ethoxylated/vessel were employed in the plate incorporation tests, each carried out without and with metabolic activation.
No cytotoxicity was noted in the plate incorporation tests, each carried out without and with metabolic activation
No increase in revertant colony numbers as compared with control counts was observed for C16-18,18'DETA-Amide_ethoxylated, tested up to 1000 µg/vessel, in any of the 5 test strains in two independent experiments without and with metabolic activation.
The positive control items showed a significant increase in the number of revertant colonies of the respective test strain and confirmed the validity of the test conditions and the sensitivity of the test system.
In conclusion, under the present test conditions, C16-18,18'DETA-Amide_ethoxylated caused no mutagenic effect in the Salmonella typhimurium strains TA 97, TA98, TA100, TA102 and TA1535 in the plate incorporation tests each carried out without and with metabolic activation.
Referenceopen allclose all
Table 1: Test results of the experiment
Test item |
Concentration |
Mitotic Index |
Aberrant cells in % |
|
|
in µg/mL |
in % |
with gaps |
without gaps |
Exposure period 4h, fixation time 24h, without S9 mix |
||||
dist.water |
10 |
14.8 |
0 |
1 |
MMC |
0.25 |
8.9 |
1 |
19 |
Test substance |
15.6 |
14.8 |
0.5 |
0.5 |
31.2 |
12.4 |
0.5 |
0.5 |
|
62.5 |
9.2 |
0.5 |
0 |
|
Exposure period 4h, fixation time 24h, with S9 mix |
||||
dist.water |
10 |
15.5 |
0 |
1.5 |
CP |
4 |
8.5 |
0 |
21 |
Test substance |
15.6 |
14.4 |
1 |
0.5 |
31.2 |
11.6 |
0 |
0.5 |
|
62.5 |
7.7 |
0 |
1.5 |
|
Exposure period 24h, fixation time 24h, without S9 mix |
||||
dist.water |
10 |
16.1 |
0 |
1 |
MMC |
0.25 |
7.8 |
2 |
23 |
Test substance |
15.6 |
13.3 |
0.5 |
0 |
31.2 |
10.8 |
0.5 |
0 |
|
62.5 |
5.7 |
0.5 |
0.5 |
- MMC: Mitomycin C; CP: Cyclophosphamide
- *: CP was fixed after 24 hours. Therefore, the mitotic index could not be calculated as percentage of control.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
It was concluded that the test substance was negative in the mammalian erythrocyte micronucleus test in vivo.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2013-03-25 until 2013-09-30
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- other: GB/T 21773-2008 Chemicals
- GLP compliance:
- yes
- Type of assay:
- other: mammalian bone marrow cells
- Specific details on test material used for the study:
- Lot: ST02697671
purity: 86.8% - Species:
- mouse
- Strain:
- other: KM mice
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Changsa Tianqin biotechnology Ltd.
- Age at study initiation:
- Weight at study initiation:
- Assigned to test groups randomly: [no/yes, under following basis: ]
- Fasting period before study:
- Housing: SPF barrier environment
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-25
- Humidity (%): 54-60
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light):
IN-LIFE DATES: From: To: - Route of administration:
- oral: gavage
- Vehicle:
- distilled water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
weight 3.75 g test substance and add distilled water to 30 mL to prepare the stock solution with the concentration of 125 mg/mL for high dose group (2500 mg/kg). Then draw 4.0 mL and 8.0 mL high dose group solution, add distilled water to 16 mL, to prepare stock solution for low dose group (625 mg/kg) and medium dose group (1259 mg/kg) animals respectively. The concentrations were 31.2, 62.5 mg/mL respectively. - Duration of treatment / exposure:
- The test substance was administered to mice at a volume of 0.2 mL/10 g bw by gavage twice during the period of 24h (at the beginning and at the 24h respectively). The solvent control group was treated by the same method. The positive control group was treated with cyclophosphamid (0.2%) by celiac injection at a volume of 0.15 ml/10 g bw.
- Frequency of treatment:
- twice, at 0 and 24 hours
- Post exposure period:
- 18 hours
- Dose / conc.:
- 2 500 mg/kg bw (total dose)
- Dose / conc.:
- 1 250 mg/kg bw (total dose)
- Dose / conc.:
- 625 mg/kg bw (total dose)
- Dose / conc.:
- 30 mg/kg bw (total dose)
- Remarks:
- positive control, Cyclophosphamide
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: celiac injection
- Doses / concentrations: 30m/kg bw - Tissues and cell types examined:
- bone marrow cells
- Details of tissue and slide preparation:
- Bone marrow cells were harvested from the sternum and cell smears were prepared and stained according to conventional procedures. The region of cell-completely, well-distributed and well-colored up was selected and examined under a microscope. 2000 polychromatic erythrocytes per animal were scored for the incidence of micronclei. The ratio of PCEs to NCEs was also determined for each animal by counting a total of 200 erythrocytes, as an indication of cytotoxicity to the bone marrow cells.
- Statistics:
- The micronucleated PCE ratios for all dose-groups and solvent control group were analyzed using the poisson distribution and that of positive control group was handled with Gaussion distribution. Each sex was analyzed respectively. The parameters and data were analyzed statistically by SPSS 13.0.
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No clinical signs were observed in any test animal. And no death occurred in any test animal during the period of the test.
The incidence of MNPCE in each treatment group were summarized Table 1. The incidence of MNPCE in solventr control groups were 1.4% and 1.6% for female and male mice respectively. The incidence of MNPCE were 1.0%, 1.7%, 1.5% for female mice and 0.8%, 1.3%, 0.9% for male mice in low, medium and high dose groups respectively, there were no significant differences compared with the solvent control (p>0.05). The incidence of MNPCE in positive control group were 24.9% and 22.6% for female and male mice respectively, there were significant differences compared with the solvent control group (p<0.01)
The result indicated, that the test substance could not increase the micronuclear rates of KM mice obviously. - Conclusions:
- It was concluded that the test substance was negative in the mammalian erythrocyte micronucleus test in vivo.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Based on the available data on genetic toxicity, there is no indication that C16 -18, 18'DETA-Amide ethoxylated induces mutagenic properties in bacterial cells or mutagenic and clastogenic properties in mammalian cells, respectively. In conclusion,
C16 -18, 18'DETA-Amide ethoxylated
does not meet the criteria for classification according to Regulation (EC) No 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.